Participants
Contact
Josep Lluis Sanfeliu, founding partner of Ysios Capital, has been interviewed by the newspaper ARA. Ysios Capital is a biomedical venture capital company that in 2011 invested €2 million in the IRB Barcelona spin-off Inbiomotion, founded by ICREA researcher Roger Gomis.
Ara newspaper (PDF in Catalan)
Related news
28 June 2012
Ysios Capital leads a two million euros investment in Inbiomotion
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
